Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism

被引：0
作者：
Li, Dan [1 ,2 ]
Li, Yujuan [1 ]
Yang, Shengjie [1 ]
Zhang, Xiaonan [3 ]
Cao, Yu [3 ]
Zhao, Ran [1 ,4 ]
Zhao, Yixi [1 ,5 ]
Jin, Xiao [1 ]
Lu, Jing [1 ,5 ]
Wang, Xinyue [1 ]
Wang, Qiutao [1 ]
Liu, Longtao [3 ]
Wu, Min [1 ]
机构：
[1] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
[4] Aerosp Ctr Hosp, Beijing, Peoples R China
[5] Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2025年 / 16卷
基金：
北京市自然科学基金; 中国国家自然科学基金;
关键词：
atherosclerosis; gut microbiota; TMAO; polydatin; hawthorn flavonoids; TRIMETHYLAMINE N-OXIDE; BLOOD-STASIS; LIPID-METABOLISM; TOXIN SYNDROME; GLUCOSE;
D O I：
10.3389/fphar.2025.1515485
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background Atherosclerosis is a widely studied pathophysiological foundation of cardiovascular diseases. Inflammation and dyslipidemia are risk factors that promote the formation of atherosclerotic plaques. The gut microbiota and their metabolites are considered independent risk factors for atherosclerosis. Polydatin combined with hawthorn flavonoids, as the extracts of Polygonum cuspidatum Sieb. et Zucc. and Crataegus pinnatifida Bunge, have shown excellent cardiovascular protective effects. However, the underlying mechanism requires further investigation. Our study aimed to explore the anti-atherosclerotic mechanism through gut microbiota and their metabolites.Methods ApoE-/- mice were fed either a normal-chow diet or a high-fat diet. The polydatin combined with hawthorn flavonoids group received varied doses of polydatin and hawthorn flavonoids: a high dose (polydatin 200 mg/kg daily; hawthorn flavonoids 100 mg/kg daily), a medium dose (polydatin 100 mg/kg daily; hawthorn flavonoids 50 mg/kg daily), and a low dose (polydatin 50 mg/kg daily; hawthorn flavonoids 25 mg/kg daily). The control and model groups were administered distilled water (0.2 mL daily). The experiment lasted for 24 weeks.Results Polydatin combined with hawthorn flavonoids administration significantly reduced lipid and inflammatory cytokine levels, meanwhile, the atherosclerotic lesions in a high-fat diet-induced ApoE-/- mice were significantly decreased. Additionally, polydatin combined with hawthorn flavonoids also inhibited the enhancement of trimethylamine N-oxide (TMAO), trimethylamine (TMA) levels of HFD-induced ApoE-/- mice by regulating the expression of hepatic flavin-containing enzyme monooxygenase 3 (FMO3). 16S rRNA sequencing results demonstrated that high-dose polydatin combined with hawthorn flavonoids treatment increased the abundance of Actinobacteriota, Atopobiaceae and Coriobacteriaea_UCG-002, and decreased the abundance of Desulfobacterota. Norank_f_Muribaculaceae was enriched in the medium-dose polydatin combined with hawthorn flavonoids and simvastatin groups, and Lactobacillus was mainly increased in the simvastatin and the low-dose polydatin combined with hawthorn flavonoids groups. According to the metagenetic results, functional annotations also suggested that the biological processes of each group mainly focused on metabolism-related processes. Specifically, polydatin combined with hawthorn flavonoids may regulate the abundance of TMA-producing bacteria (Coriobacteriaceae, Desulfovibrio, Muribaculum, and Clostridium) and related enzymes in glycolipid metabolic pathways to exert an important effect on the prevention of atherosclerosis.Conclusion Our results suggested that polydatin combined with hawthorn flavonoids could regulate the glucolipid metabolism-related pathway, attenuate inflammatory cytokine levels, and reduce atherosclerotic plaques by remodeling gut microbiota.
引用
收藏
页数：22
相关论文
共 80 条
  • [1] Arauna D., Furrianca M., Espinosa-Parrilla Y., Fuentes E., Alarcon M., Palomo I., Natural bioactive compounds as protectors of mitochondrial dysfunction in cardiovascular diseases and aging, Mol. Basel, Switz, 24, 23, (2019)
  • [2] Ballard-Hernandez J., Sall J., Dyslipidemia update, Nurs. Clin. N. Am, 58, 3, pp. 295-308, (2023)
  • [3] Bansilal S., Castellano J.M., Fuster V., Global burden of CVD: focus on secondary prevention of cardiovascular disease, Int. J. Cardiol, 201, pp. S1-S7, (2015)
  • [4] Blagov A.V., Markin A.M., Bogatyreva A.I., Tolstik T.V., Sukhorukov V.N., Orekhov A.N., The role of macrophages in the pathogenesis of atherosclerosis, Cells, 12, 4, (2023)
  • [5] Bolte L.A., Vich Vila A., Imhann F., Collij V., Gacesa R., Peters V., Et al., Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome, Gut, 70, 7, pp. 1287-1298, (2021)
  • [6] Cai Y.Y., Huang F.Q., Lao X., Lu Y., Gao X., Alolga R.N., Et al., Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis, NPJ biofilms microbiomes, 8, 1, (2022)
  • [7] Chang T.T., Chen J.W., Direct CCL4 inhibition modulates gut microbiota, reduces circulating trimethylamine N-oxide, and improves glucose and lipid metabolism in high-fat-diet-induced diabetes mellitus, J. Inflamm. Res, 14, pp. 6237-6250, (2021)
  • [8] Chen Y., Weng Z., Liu Q., Shao W., Guo W., Chen C., Et al., FMO3 and its metabolite TMAO contribute to the formation of gallstones, Biochimica biophysica acta Mol. basis Dis, 1865, 10, pp. 2576-2585, (2019)
  • [9] Cho C.E., Taesuwan S., Malysheva O.V., Bender E., Tulchinsky N.F., Yan J., Et al., Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial, Mol. Nutr. and food Res, 61, 1, (2017)
  • [10] Diez-Ricote L., Ruiz-Valderrey P., Mico V., Blanco R., Tome-Carneiro J., Davalos A., Et al., TMAO upregulates members of the miR-17/92 cluster and impacts targets associated with atherosclerosis, Int. J. Mol. Sci, 23, 20, (2022)
12345678